Insights On Outsourced Drug Development

1. Preclinical Evaluation Of New Antifibrotics In NASH-Induced Fibrosis Models 6/10/2025

   Accelerate the development of antifibrotic therapies through our clinically relevant models, deep scientific expertise, and proven preclinical capabilities in this area of unmet medical need.

2. Introducing SUPR 3/28/2025

   Validating the performance of Getinge 50L and 250L single-use bioreactors alongside smaller-scale systems can optimize production processes and ensure scalability for CHO cell cultivation.

3. Rapid Automated Selection Of Mammalian Cell Colonies 3/17/2025

   Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.

4. A Checklist For Efficient And Reliable Gene Therapy Manufacturing 6/3/2024

   Gain insight into how to design and execute an efficient upstream AAV production process, and follow the checklist within to ensure all appropriate factors are considered at each phase of drug development.

5. Streamlining Biologics Development: Leveraging Small-Scale Studies For Greater Efficiency 9/25/2025

   Uncover how a data-driven approach to small-scale studies not only accelerates development timelines but also enhances decision-making and resolves full-scale manufacturing challenges across diverse biologic modalities.

6. Cost And Scalability Key Drivers Of Expanded Gene Therapy Access 5/16/2025

   Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

7. Improving API Solubility Using Spray Drying With Polyvinyl Alcohol 6/5/2025

   Enhancing the solubility of poorly soluble APIs is vital for improving bioavailability. Discover how advanced formulation techniques like hot-melt extrusion and spray drying can overcome this challenge.

8. Assessing Viability And Real-Time Apoptosis/Necrosis 3/17/2025

   Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.

9. Streamlining 3D Cancer Assays With Automated Innovations 5/13/2024

   Gain insight into the use of 3D cultured cancer models in the search for new therapies for complex diseases like cancer.

10. Simplify CAR-T Cell Manufacturing With LNP-Mediated Delivery 6/3/2025

    Streamline CAR-T cell manufacturing with lipid nanoparticles delivering base editors to create fratricide-resistant, CD45-edited CAR45 T cells, which enables scalable, precise, and potent therapies for blood cancers.